A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
NCT07310420
This study is recruiting at 26 US sites in 16 states, according to its ClinicalTrials.gov record last updated .
Summary
The primary objective of this trial is to evaluate ovarian suppression following treatment with ZOLADEX 10.8 mg by luteinizing hormone (LH) within each cohort.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Advanced Breast Cancer
- Early Breast Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 to 55 years
- Sex
- Female
- Healthy volunteers
- Not accepted
- Sponsor
- TerSera Therapeutics LLC
- Last updated on ClinicalTrials.gov
- October 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arkansas · 1
- Genesis Cancer and Blood Institute · Hot Springs, AR
District of Columbia · 1
- MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center · Washington D.C., DC
Florida · 1
- Cancer Centers of Florida · Ocoee, FL
Georgia · 2
- University Cancer & Blood Center, LLC · Athens, GA
- Summit Cancer Care · Savannah, GA
Illinois · 5
- University of Illinois at Chicago · Chicago, IL
- NorthShore University Health System - Evanston Hospital · Evanston, IL
- Duly Health and Care · Lisle, IL
- Orchard Healthcare Research · Skokie, IL
- Springfield Clinic - The Cancer Center · Springfield, IL
Iowa · 1
- Mission Cancer and Blood · Des Moines, IA
Louisiana · 1
- Ochsner Medical Center (OMC) · New Orleans, LA
Michigan · 1
- Profound Research LLC at Michigan Hematology and Oncology Consultants · Royal Oak, MI
Montana · 1
- St. Vincent Frontier Cancer Center (SVFCC) - Billings (Frontier Cancer Center and Blood Institute) · Billings, MT
New Mexico · 1
- San Juan Oncology Associates · Farmington, NM
New York · 4
- New York Oncology Hematology - Amsterdam Cancer Center · Amsterdam, NY
- Chelsea Medical Center at Mount Sinai · New York, NY
- Montefiore Medical Center · The Bronx, NY
- Clinical Research Alliance Inc · Westbury, NY
North Carolina · 1
- WakeMed Cancer Care - Waverly Hematology & Medical Oncology · Cary, NC
Ohio · 2
- Cleveland Clinic Foundation · Cleveland, OH
- The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc. · Columbus, OH
Pennsylvania · 2
- St. Luke's University Health Network · Bethlehem, PA
- Guthrie Medical Group · Sayre, PA
Texas · 1
- Oncology Consultants PA · Houston, TX
Washington · 1
- Cancer Care Northwest · Spokane, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.